Inventor

TAKECHI KAZUO

JP16 patents

⚠️ This page may combine multiple inventors who share the name “TAKECHI KAZUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GREEN CROSS CORP

11 patents

US5130244AJul 14, 1992

Stable aqueous thrombin solution

GREEN CROSS CORP79 citations93

US5138034AAug 11, 1992

Method of fractionating plasma proteins

GREEN CROSS CORP54 citations92

US5132406AJul 21, 1992

Method of producing immunoglobulin preparations for intravenous injection

GREEN CROSS CORP24 citations92

US4740498AApr 26, 1988

Fibronectin preparations

GREEN CROSS CORP26 citations92

US5151499ASep 29, 1992

Production method for protein-containing composition

GREEN CROSS CORP25 citations90

US4876088AOct 24, 1989

Gamma-globulin injectable solutions containing sorbitol

GREEN CROSS CORP20 citations81

US4104125AAug 1, 1978

Process for producing human lysozyme

GREEN CROSS CORP20 citations79

US4845199AJul 4, 1989

Process for heat treating chemically unmodified gamma-globulin

GREEN CROSS CORP9 citations73

US5589516ADec 31, 1996

Liquid preparation of antithrombin-III and stabilizing method therefor

GREEN CROSS CORP8 citations70

US5277818AJan 11, 1994

Albumin preparation and process for preparing the same

GREEN CROSS CORP14 citations70

US4017470AApr 12, 1977

Method for preparing a heat-stable plasma protein solution from paste IV-1

GREEN CROSS CORP15 citations66

ALPHA THERAPEUTIC CORP

5 patents

US5616693AApr 1, 1997

Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste

ALPHA THERAPEUTIC CORP44 citations91

US6162904ADec 19, 2000

Manufacturing method for intraveneously administrable immune globulin and resultant product

ALPHA THERAPEUTIC CORP34 citations89

US6504012B2Jan 7, 2003

Method for preparing dual virally inactivated immune globulin for intravenous administration

ALPHA THERAPEUTIC CORP9 citations70

US6441144B1Aug 27, 2002

Method for repairing dual virally inactivated immune globulin for intravenous administration

ALPHA THERAPEUTIC CORP5 citations70

US5981715ANov 9, 1999

Process for increasing the yield of a protein which has been subjected to viral inactivation

ALPHA THERAPEUTIC CORP11 citations68